Ningbo David Medical Device Co., Ltd. (SHE:300314)
China flag China · Delayed Price · Currency is CNY
12.28
+0.69 (5.95%)
Aug 14, 2026, 3:04 PM CST

SHE:300314 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
74.3787.0557.26147.6197.3680.21
Depreciation & Amortization
24.2324.2326.7227.3225.5124.55
Other Amortization
5.335.333.560.09--
Loss (Gain) From Sale of Assets
0.390.390.010.23-0.02-0.12
Asset Writedown & Restructuring Costs
0.020.020.531.61-0.881.95
Loss (Gain) From Sale of Investments
-15.31-15.3110.06-11.595.78-15.99
Provision & Write-off of Bad Debts
1.271.270.230.51.22-
Other Operating Activities
14.667.23.77-4.6-16.172.89
Change in Accounts Receivable
-25.97-25.97-2.03-9.05-5.6-3.14
Change in Inventory
-19-19-31.05-12.27-11.4-35.31
Change in Accounts Payable
23.7423.7426.78-4.0414.66-3.16
Operating Cash Flow
84.0389.2593.87135.2111.5751.48
Operating Cash Flow Growth
16.78%-4.92%-30.57%21.18%116.72%-62.62%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-41.82-55.03-139.69-40.39-49.78-6.53
Sale of Property, Plant & Equipment
0.430.430.050.590.020.28
Investment in Securities
131.41131.41-130107.5-2.593.5
Other Investing Activities
-2.29-26.347.034.0611.4119.44
Investing Cash Flow
87.7350.47-262.6171.76-40.85106.69

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Repaid
--3.44-5.02-2.51-4.08-0.47
Net Debt Issued (Repaid)
-3.44-3.44-5.02-2.51-4.08-0.47
Common Dividends Paid
-25.06-25.06-51.84-43.2-28.8-43.2
Financing Cash Flow
-28.5-28.5-56.86-45.71-32.88-43.67

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-9.99-4.87-0.296.3317.05-2.87
Net Cash Flow
133.27106.35-225.9167.5854.89111.63

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
42.2134.22-45.8294.8161.7944.95
Free Cash Flow Growth
---53.43%37.48%-60.41%
Free Cash Flow Margin
7.33%5.86%-8.70%15.33%12.21%9.48%
Free Cash Flow Per Share
0.140.12-0.160.330.220.16
Levered Free Cash Flow
21.99-0.69-60.3965.5625.7618.97
Unlevered Free Cash Flow
22.02-0.42-60.0965.9325.9718.99

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
22.5920.8522.1256.9634.8233.17
Change in Working Capital
-20.94-20.94-8.28-25.97-1.23-42.02